Feltl and Company Issues 2015 Top Stock Ideas

Feltl and Company introduced its 2015 Top Ideas List:

Cabela’s Inc. (NYSE: CAB) (Buy, $62 PT) - Analyst: Mark Smith - Same-store sales face easy prior year comps. CAB comped (21.7%), (14.2%) and (11.2%), respectively in 1Q through 3Q of 2014. We think the company has potential for double digit same-store sales growth early in the year

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) (Strong Buy, $21.75 PT) - Analyst: Ben Haynor - Currently, there are no pharmaceuticals approved for a mild DFI indication, despite over a half million cases occurring in the US annually.

EVINE Live Inc. (NASDAQ: EVLV) (Buy, $7 PT) - Analyst: Mark Smith - We think the company is getting its footing following a tumultuous year in 2014. Last year EVLV experienced activist investors, a turnover in CEO and members of the board, a name change and changes to the strategy going forward. We think these have been positive developments that are beginning to bear fruit. EVLV has outperformed expectations for the last few quarters and we think investors are getting more comfort with management and the new strategies.

InnerWorkings (NASDAQ: INWK) (Buy, $10 PT) - Analyst Randy Hugen - The $500 billion global print industry currently outsources a low-single-digit percentage of procurement while BPO of other non-core functions runs in the 10%-40% range, suggesting INWK has significant growth potential.

Integrated Silicon Solutions (NASDAQ: ISSI) (Buy, $18.50 PT) - Analyst: Jeffrey Schreiner - We believe ISSI is well positioned as a long-term supplier in the end markets it serves. We estimate ISSI has improved its market position within the industrial end markets as it remains a stable supplier, while also benefiting from expansion of its global distribution.Integrated Silicon Solutions (NASDAQ: ISSI)

The Joint Corp. (NASDAQ: JYNT) (Strong Buy, $12.45) - Analyst: Brent Rystrom - The Joint is a leading franchisor of a disruptive chiropractor store. These stores offer walk-in service, low costs ($22 average treatment), direct billing (no insurance billing or collection hassles), and highly attractive doctor economics. JYNT has 231 franchises open and operating and another 250 sold and in the process of development over the next 3-4 years.

Life Time Fitness (NYSE: LTM) (Buy, $70 PT) - Analyst: Brent Rystrom - LTM is exploring the possibility of splitting into two companies, an operating company (OpCo) that would lease its centers from a real estate company (PropCo).... PropCo component of an LTM split could trade at a value of $50 to $60 or more per LTM share... We believe the OpCo would be a much smaller company, generating free cash flow near about $75mm to $100mm annually, and likely attaining a valuation near $15 to $20 per LTM share

Synaptics (NASDAQ: SYNA) (Buy, $80 PT) - Analyst: Jeffrey Schreiner - In CY15 we see potential headwinds which may slow smartphone touch IC growth, suggesting touch may not offer the same leadership it previously provided... Following its acquisition of Validity in late CY13, SYNA entered the fingerprint market. The fingerprint sensor market had historically been based on notebooks, but due to the inclusion of a fingerprint sensor in the AAPL iPhone 5s, the fingerprint market is now seeing broader adoption into smartphones/tablets.

Tearlab (NASDAQ: TEAR) (Strong Buy, $5 PT) - Analyst: Ben Haynor - While 2014 was a disappointing year for the company as they struggled to get the appropriate selling and customer education strategies in place and work through the utilization issues created by the prior strategy, we believe the worst is now behind the company and Street estimates are reasonable.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• Meta Platforms Inc. (META) PT Lowered to $540 at Jefferies, 'Buy the Zuck Shopping Cart Dip'
• Meta Platforms Inc. (META) PT Lowered to $520 at Barclays, “Investment Cycle With No Revenue”